Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 4INDUSTRY 3

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 648Thoracic 198Genitourinary 155Lymphoid 113Breast 99Head & Neck 82Gynecologic 60Sarcoma 58Tumor-Agnostic 30Other solid neoplasm 28Other hematologic neoplasm 14CNS 13Dermatologic 10Plasma cell 8Myeloid 4Endocrine 1Classical hematology 1

Conditions

Lymphoma, Extranodal NK-T-Cell 2Lymphohistiocytosis, Hemophagocytic 2Neoplasms 1Myeloproliferative Disorders 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Carcinoma, Transitional Cell 1

Interventions

Cyclophosphamide 229fludarabine phosphate 206fludarabine 163Busulfan 150Mycophenolic Acid 135Tacrolimus 133Whole-Body Irradiation 132Peripheral Blood Stem Cell Transplantation 121Cytarabine 101Azacitidine 100Antilymphocyte Serum 98Melphalan 96Cyclosporine 96Methotrexate 87Imatinib Mesylate 87Filgrastim 85Decitabine 66Granulocyte Colony-Stimulating Factor 60Thiotepa 57venetoclax 53Stem Cell Transplantation 53thymoglobulin 51Radiotherapy 49Cord Blood Stem Cell Transplantation 42nilotinib 40Clofarabine 38Dasatinib 37Methylprednisolone 36ruxolitinib 35Etoposide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Gemcitabine × Myeloid × Clear all
NCT04999878 2021-08-11

RUE-DDGP

Zhengzhou University

Phase 4 Unknown
30 enrolled
LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT04405375 2020-05-28

GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

Beijing Tongren Hospital

Phase 2 Unknown
29 enrolled
LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT00003727 2019-11-04

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia

University of Maryland, Baltimore

Phase 2 Completed
22 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00588666 2016-01-22

Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
51 enrolled 7 charts
GenitourinaryMyeloid

Carcinoma, Transitional Cell, Myeloproliferative Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡